GlassScriptPhysician profile
Eric G Huish
NPI 1790777969
$2,922.91
in general payments reported to CMS, 2019-2025
33 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $303 · 2021: $587 · 2022: $456 · 2023: $475 · 2024: $677 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.78 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $268.08 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $250.88 | 2021-2024 | |
| Myovant Sciences INC. | $249.64 | 2021-2022 | |
| Millicent US INC | $183.87 | 2020-2024 | Intrarosa, Femring |
| Coopersurgical, INC. | $169.70 | 2019-2024 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $160.10 | 2023-2024 | Myfembree |
| Stryker Corporation | $148.46 | 2024 | |
| Minerva Surgical, INC | $125.19 | 2024-2025 | |
| Mylan Pharmaceuticals INC. | $100.76 | 2020-2022 | |
| Hologic Sales and Service, LLC | $82.60 | 2019-2024 | Aptima |
| Amag Pharmaceuticals, INC. | $78.66 | 2019-2021 | |
| Therapeuticsmd, INC. | $76.82 | 2020-2021 | |
| Shield Therapeutics INC | $66.60 | 2022-2025 | Accrufer |
| Exeltis, USA INC. | $59.95 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $53.64 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $53.30 | 2021 | |
| Boston Scientific Corporation | $48.09 | 2019-2020 | |
| Becton, Dickinson and Company | $39.56 | 2022-2023 | Bd Onclarity |
| Evofem Biosciences, INC. | $32.88 | 2021-2023 | Phexxi |
| Organon LLC | $31.52 | 2022-2024 | |
| Cook Medical LLC | $29.82 | 2023 | Guardia, Cook |
| Daiichi Sankyo INC. | $28.46 | 2019-2020 | |
| Coloplast Corp | $25.28 | 2019 | |
| Astellas Pharma US INC | $24.69 | 2025 | Veozah |
| Baxter Healthcare | $20.81 | 2024 | Tisseel |
| Pacira Pharmaceuticals Incorporated | $18.36 | 2022 | |
| Smith+Nephew, INC. | $17.75 | 2025 | Pico 7, Pico 14 |
| Alydia Health | $15.57 | 2021 | |
| Ethicon US, LLC | $15.30 | 2019 | |
| Optumhealth Care Solutions, LLC | $14.75 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Avion Pharmaceuticals | $13.25 | 2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Huish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.